An AI-Driven Genomics Company Is Turning to Drugs
Will Knight, MIT Technology Review
The next blockbuster drug could be developed with help from machine learning techniques.
Deep Genomics, a Canadian company that uses machine learning to trace potential genetic causes for disease, announced Tuesday that it’s getting into drug development. It joins a growing list of AI ...